Safety and Efficacy of Pegylated Exenatine Injection (PB-119) in Drug-naïve T2DM Subjects
Status:
Recruiting
Trial end date:
2023-06-13
Target enrollment:
Participant gender:
Summary
A randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of
24 once-weekly subcutaneous doses of PB-119 in Drug-naïve T2DM Subjects.